The grouping of breast tumor samples in the AHSB + FIVO cohorts, according to their pathological classification, showed that RRAS2 overexpression was found in all types of tumors, from in situ to infiltrating carcinomas (Fig. 5b). The gene discussed is RRAS2; the disease is breast neoplasm.